Core Insights - The article discusses potential investment opportunities in LLY, indicating a possible long position within the next 72 hours [1]. Group 1 - The analyst has no current stock or derivative positions in the companies mentioned but may initiate a beneficial long position in LLY [1]. - The article expresses the author's own opinions and is not influenced by compensation from any company [1]. - There is no business relationship with any company whose stock is mentioned in the article [1].

Pre-market futures are up this morning, though somewhat muted from levels prior to economic reports out this morning on unemployment claims. We also see a full compliment of Q1 earnings reports ahead of today’s opening bell, with another couple “Mag 7” companies due to report after today’s close.Jobless Claims Jump Higher Last WeekFor months, we’ve been talking in this space about the steadiness and resiliency of weekly unemployment claims. While other metrics on the economy and employment have begun to sho ...

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.CVS Health Corporation (NYSE: CVS ) announced its Q1 2025 earnings earlier today, and the market's response appears to be very positive - shares are up >7% at the time of w ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

CVS Health (CVS) reported $94.59 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 7%. EPS of $2.25 for the same period compares to $1.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $92.95 billion, representing a surprise of +1.76%. The company delivered an EPS surprise of +31.58%, with the consensus EPS estimate being $1.71.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

CVS Health Corporation (CVS) posted adjusted earnings per share (EPS) of $2.25 in the first quarter of 2025, up 71.8% year over year. The metric also topped the Zacks Consensus Estimate by 34.7%. The adjusted EPS figure considers certain asset amortization costs, loss on assets held for sale and other adjustments. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)On a reported basis, the company’s GAAP earnings were $1.41 per share compared with 88 cents in the prior-year period.CVS’ ...

CVS Health (CVS) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 31.58%. A quarter ago, it was expected that this drugstore chain and pharmacy benefits manager would post earnings of $0.89 per share when it actually produced earnings of $1.19, delivering a surprise of 33.71%.Over the ...

CVS Health (CVS) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Speaker0 Good morning, and thank you all for attending the CVS Health Q1 twenty twenty five Earnings Conference Call. My name is Breeka, and I will be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. I would now like to pass the conference over to your host, Larry McGrath, Chief Strategy Officer. Thank you. You may proceed, Larry. Speaker1 Goo ...

CVS Health (CVS) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEODavid Joyner - President & CEOThomas Cowhey - Executive Vice President & CFOSteve Nelson - Executive Vice President and President, AetnaLisa Gill - Managing DirectorPrem Shah - Executive Vice President and Group PresidentAndrew Mok - DirectorCharles Rhyee - Managing Director Conference Call Participants Justin Lake - Analyst - Healthcar ...

First Quarter 2025 May 1, 2025 Earnings Conference Call J. David Joyner President and Chief Executive Officer Thomas F. Cowhey Executive Vice President and Chief Financial Officer 1 ©2025 CVS Health and/or one of its affiliates. Confidential and proprietary. Cautionary Statement concerning forward-looking statements This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Heal ...